Alex Telford

Alex Telford, founder of Convoke and biotech blogger since 2019, dives into the evolving landscape of the pharmaceutical industry. He discusses the intricate journey of drug development, emphasizing the role of AI in enhancing drug discovery and the regulatory challenges surrounding it. Telford also explores the economics of blockbuster drugs and the balance between affordability and innovation. With insights into the future of biotechnology, including CRISPR and CAR T therapies, he paints an optimistic picture of what's next for medicine.

In this engaging discussion, Alex Telford, Co-founder and CEO of Convoke, dives into the pivotal role of forecasting in biopharma development, emphasizing its strategic importance in preclinical stages. He also highlights the transformative potential of technology, such as natural language processing, to reshape data analysis and improve collaboration in the industry. Alex shares insights on bridging the gap between biotech and tech cultures, the necessity of a writing culture in growing companies, and the value of diverse reading habits for industry professionals.